GSK plc (NYSE:GSK) Q4 2023 Earnings Call Transcript January 31, 2024 GSK plc misses on earnings expectations. Reported EPS is $0.72 EPS, expectations were $0.76. GSK isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Nick Stone: Hello, everyone. It’s Nick Stone, […]
U.K. stocks finished down Wednesday, with the FTSE 100 Index falling 0.47% at 7,630.57. Among FTSE 100 constituents, advertising/marketing/public relations.
Wednesday, GSK Plc (NYSE:GSK) reported fourth-quarter adjusted operating profit of £1.75 billion, up 10% at the actual exchange rate (AER) and up 21% at the constant exchange rate (CER). The company’s RSV vaccine, Arexvy, hit £1.2 billion in sales in 2023 and £529 million in the fourth quarter. Approximately 6 million of the 83 million U.S. adults aged 60 and older at risk have been vaccinated with Arexvy. The company reported sales of $10 billion (£8.1 billion), beating the consensus of $9.61 b